Related references
Note: Only part of the references are listed.Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
Jyh-Ming Liou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)
Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why
David Y. Graham et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy
David Y. Graham et al.
GUT (2022)
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
Timothy M. Walker et al.
LANCET MICROBE (2022)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Peter Malfertheiner et al.
GUT (2022)
Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis br
Masoud Keikha et al.
MICROBIAL PATHOGENESIS (2022)
Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis
Ebrahim Kouhsari et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2022)
Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
Olga P. Nyssen et al.
FRONTIERS IN MICROBIOLOGY (2022)
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications
Evariste Tshibangu-Kabamba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides
Eva Kocsmar et al.
NATURE COMMUNICATIONS (2021)
Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept
Eva Kocsmar et al.
HELICOBACTER (2020)
Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance
Seung In Seo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Jyh-Ming Liou et al.
GUT (2020)
Perspective for Precision Medicine for Tuberculosis
Christoph Lange et al.
FRONTIERS IN IMMUNOLOGY (2020)
Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment Failure
Behtash G. Nezami et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial
Sungmoon Ong et al.
HELICOBACTER (2019)
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
Jyh-Ming Liou et al.
GASTROENTEROLOGY (2018)
A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori
You-hua Wang et al.
HELICOBACTER (2018)
14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial
Jyh-Ming Liou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials
Mei-Jyh Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
Enzo Ierardi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Hp-normogram (normo-graham) for Assessing the Outcome of H-pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype
David Y. Graham
HELICOBACTER (2016)
Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance
Francis Megraud et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
Jyh-Ming Liou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance
Hyun Jeong Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh-Ming Liou et al.
LANCET (2013)
Genotypic Resistance in Helicobacter pylori Strains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies
Jyh-Ming Liou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Rescue regimens after Helicobacter pylori treatment failure
Javier P. Gisbert
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Helicobacter pylori detection and antimicrobial susceptibility testing
Francis Megraud et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori
V De Francesco et al.
ANNALS OF INTERNAL MEDICINE (2006)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)